Table 2.
Drug Classification & Type | Outpatient Surveillance (N = 5705) |
Cross Sectional (N = 303) |
||
---|---|---|---|---|
n | % | n | % | |
Antimalarial | 753 | 13.2 | 57 | 18.8 |
Amodiaquine | 203 | 3.6 | 21 | 6.9 |
Artemether | 160 | 2.8 | 7 | 2.3 |
Artemether-Lumefantrine | 52 | 0.9 | 3 | 1.0 |
Artesunate | 12 | 0.2 | 1 | 0.3 |
Chloroquine | 240 | 4.2 | 20 | 6.6 |
Dihydroartemisinin-Piperaquine | 1 | 0.02 | 0 | 0 |
Doxycycline | 91 | 1.6 | 2 | 0.6 |
Primaquine | 13 | 0.2 | 1 | 0.3 |
Quinine | 6 | 0.1 | 0 | 0 |
Sulfadoxine-Pyrimethamine | 461 | 8.1 | 42 | 13.9 |
Antibiotic | 4147 | 72.7 | 223 | 73.4 |
Amoxicillin | 1429 | 25.0 | 124 | 40.9 |
Co-trimoxazole | 1179 | 20.7 | 70 | 23.1 |
Benzylpenicillin | 478 | 8.4 | 42 | 13.9 |
Chloramphenicol | 129 | 2.3 | 12 | 4.0 |
Metronidazole | 32 | 0.6 | 3 | 1.0 |
Erythromycin | 49 | 0.9 | 1 | 0.3 |
Eye ointment | 20 | 0.4 | 1 | 0.3 |
Analgesic/antipyretic | 4068 | 71.3 | 221 | 72.9 |
Aspirin | 261 | 4.6 | 28 | 9.2 |
Paracetamol | 3765 | 66.0 | 190 | 62.7 |
Indomethacin | 32 | 0.6 | 3 | 1.0 |
Haematinics | 438 | 7.7 | 10 | 3.3 |
Ferrous salt + folic acid | 419 | 7.3 | 9 | 2.9 |
Interferon | 19 | 0.3 | 1 | 0.3 |
Gastro Intestinal | 19 | 0.3 | 5 | 1.7 |
Cimetidine | 4 | 0.1 | 1 | 0.3 |
Aluminium-Hydroxide | 15 | 0.3 | 3 | 1.0 |
Anti-diabetic | 3 | 0.1 | 0 | 0 |
Metaformin | 3 | 0.1 | 0 | 0 |
Anticonvulsant | 2 | 0.04 | 1 | 0.3 |
Phenobarbitone | 0 | 0 | 1 | 0.3 |
Antiprotozoal | 343 | 6.0 | 17 | 5.6 |
Tinidazole | 343 | 6.0 | 16 | 5.3 |
Anthelminthic | 1022 | 17.9 | 50 | 16.5 |
Albendazole | 1022 | 17.9 | 42 | 13.9 |
Corticosteroid | 0 | 0 | 1 | 0.3 |
Prednisolone | 0 | 0 | 1 | 0.3 |
Bronchodilator | 76 | 1.3 | 0 | 0 |
Salbutamol | 74 | 1.3 | 0 | 0 |
Antifungal | 12 | 0.2 | 1 | 0.3 |
Dermatological lotion | 7 | 0.1 | 1 | 0.3 |
Dermatological oral drugs | 5 | 0.1 | 0 | 0 |
Cardio-vascular | 3 | 0.1 | 0 | 0 |
Methyldopa | 3 | 0.1 | 0 | 0 |
Rehydration | 82 | 1.4 | 0 | 0 |
Oral rehydration salts | 73 | 1.3 | 1 | 0.3 |
Glucose | 9 | 0.2 | 0 | 0 |